Once again, researchers at Penn’s Abramson Cancer Center have extended the reach of the immune system in the fight against metastatic melanoma, this time by combining the checkpoint inhibitor tremelimumab with an anti-CD40 monoclonal antibody drug.
Perelman School of Medicine
Penn Medicine: Investigational Personalized Cellular Therapy Tolerated Well by Patients with Advanced Mesothelioma, Ovarian and Pancreatic Cancers
Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Per
RNA is both the bridge between DNA and the production of proteins that carry out the functions of life and what guides which and how much protein gets made.
Two Different Carotid Artery Stenting Procedures Show Little Difference in Effectiveness, According to Penn Medicine Study
P.J. Brennan of the Perelman School of Medicine it quoted on patient satisfaction as a factor in better patient care.
Understanding the molecular signals that guide early cells in the embryo to develop into different types of organs provides insight into how tissues regenerate and repair themselves.
Glenn Bryan of Government and Community Affairs,
Corey Langer, Lynn Schuchter and